Thermo Fisher Scientific

Equities

TMO

US8835561023

Advanced Medical Equipment & Technology

Real-time Estimate Cboe BZX Other stock markets 10:52:59 2024-05-10 am EDT			5-day change	1st Jan Change
592.1 ^USD	+2.45%		+3.16%	+11.24%

02:17pm	UK Competition Regulator Opens Probe on Thermo Fisher, Olink Merger	MT
01:50pm	UK Competition Watchdog Opens Probe on Thermo Fisher Scientific's Acquisition of Olink	MT

Thermo Fisher Scientific Inc. Declares Quarterly Cash Dividend, Payable on July 14, 2023

May 24, 2023 at 05:00 pm EDT

Thermo Fisher Scientific Inc. announced that its Board of Directors authorized a quarterly cash dividend of $0.35 per common share, payable on July 14, 2023, to shareholders of record as of June 15, 2023.

Latest news about Thermo Fisher Scientific

UK Competition Regulator Opens Probe on Thermo Fisher, Olink Merger	08:17am	MT
UK Competition Watchdog Opens Probe on Thermo Fisher Scientific's Acquisition of Olink	07:50am	MT
UK's CMA kicks off probe into Thermo Fisher-Olink deal	07:10am	RE
Bio-Rad Laboratories reiterates 2024 revenue growth outlook; shares slip	May. 07	RE
Thermo Fisher Scientific Insider Sold Shares Worth $5,737,356, According to a Recent SEC Filing	May. 02	MT
Jefferies Adjusts Price Target on Thermo Fisher Scientific to $600 From $540	May. 01	MT
Thermo Fisher Scientific Insider Sold Shares Worth $1,135,880, According to a Recent SEC Filing	Apr. 29	MT
HSBC Raises Thermo Fisher Scientific's Price Target to $670 From $660	Apr. 29	MT
Bio-Techne to Enter Product Distribution Deal With Thermo Fisher Scientific	Apr. 29	MT
Bio-Techne Corporation Announces New Distribution Agreement with Thermo Fisher Scientific	Apr. 29	CI
Raymond James Adjusts Price Target on Thermo Fisher Scientific to $650 From $605, Keeps Outperform Rating	Apr. 29	MT
Redburn Atlantic Adjusts Price Target on Thermo Fisher Scientific to $620 From $615	Apr. 26	MT
Deutsche Bank Adjusts Price Target on Thermo Fisher Scientific to $610 From $600	Apr. 25	MT
TD Cowen Adjusts Price Target on Thermo Fisher Scientific to $648 From $644	Apr. 25	MT
Bernstein Adjusts Thermo Fisher Scientific Price Target to $553 From $544	Apr. 25	MT
JPMorgan Adjusts Thermo Fisher Scientific Price Target to $650 From $600	Apr. 25	MT
Morgan Stanley Raises Price Target on Thermo Fisher Scientific to $650 From $620, Keeps Overweight Rating	Apr. 25	MT
Stifel Adjusts Price Target on Thermo Fisher Scientific to $600 From $595	Apr. 25	MT
Goldman Sachs Adjusts Price Target on Thermo Fisher Scientific to $650 From $640	Apr. 25	MT
Barclays Adjusts Price Target on Thermo Fisher Scientific to $615 From $590	Apr. 25	MT
RBC Adjusts Price Target on Thermo Fisher Scientific to $662 From $657	Apr. 25	MT
Wolfe Research Raises Thermo Fisher Scientific's Price Target to $625 From $615	Apr. 24	MT
Baird Trims Thermo Fisher Scientific's Price Target to $620 From $621	Apr. 24	MT
Top Midday Stories: Tesla, Boston Scientific Shares Jump Post-Earnings; Major Airline Stocks Down on New DOT Rules; B. Riley Finally Submits 10-K, Sends Stock Soaring	Apr. 24	MT
Global markets live: Heineken, AT&T Hasbro, Visa, Boeing...	Apr. 24

Chart Thermo Fisher Scientific

Duration

Period

More charts

Company Profile

Thermo Fisher Scientific Inc. specializes in the design, manufacturing and marketing of laboratory and scientific equipments. Net sales (including intragroup) break down by family of products as follows: - laboratory equipments (70%). Moreover, the group proposes chemical products (reagents, solvent, salts, etc.), consumable products (tubes, funnels, vials, etc.), as well as conditioning, warehousing, storage, etc.; - diagnostics equipment and products (15.3%); - scientific analysis equipments (14.7%): analyzer (of water, gas, grounds, etc.), mass spectrometers, molecular spectroscopes, microscopes, manometers, samplers, microbiology equipments, reactive agents, etc. Net sales break down by source of income into products sales (78.5%) and services (21.5%). Net sales break down geographically as follows: North America (53%), Europe (25.7%), Asia-Pacific (18.1%) and others (3.2%).

Sector

Advanced Medical Equipment & Technology

Calendar

2024-05-14 - BofA Securities Health Care Conference

Related indices

S&P 500

More about the company

Income Statement Evolution

More financial data

Ratings for Thermo Fisher Scientific

Trading Rating

Investor Rating

ESG Refinitiv

More Ratings

Analysts' Consensus

Sell

Buy

Mean consensus

OUTPERFORM

Number of Analysts

Last Close Price

577.9 USD

Average target price

625.5 USD

Spread / Average Target

+8.23%

Consensus

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar

Sector Other Advanced Medical Equipment & Technology

	1st Jan change	Capi.
THERMO FISHER SCIENTIFIC	+11.24%	221B
DANAHER CORPORATION	+9.17%	186B
INTUITIVE SURGICAL, INC.	+14.60%	137B
BOSTON SCIENTIFIC CORPORATION	+28.34%	109B
SIEMENS HEALTHINEERS AG	-0.04%	63.09B
EDWARDS LIFESCIENCES CORPORATION	+14.92%	52.68B
SHENZHEN MINDRAY BIO-MEDICAL ELECTRONICS CO., LTD.	+4.86%	50.86B
AGILENT TECHNOLOGIES, INC.	+7.49%	42.53B
GE HEALTHCARE TECHNOLOGIES INC.	+7.14%	37.76B
RESMED, INC.	+24.09%	31.86B

Other Advanced Medical Equipment & Technology